
Corcept Therapeutics innovates in modulating cortisol's effects for various health conditions.
Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). The Associate Director, Statistical Programming is responsible for planning, execution, and quality of SAS programming to conduct statistical analyses in support of clinical trial results.
Corcept Therapeutics innovates in modulating cortisol's effects for various health conditions.